Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-17-012320
Filing Date
2017-01-18
Accepted
2017-01-18 16:02:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 FILED PURSUANT TO RULE 424(B)(5) d326815d424b5.htm 424B5 239025
2 GRAPHIC g326815g04j69.jpg GRAPHIC 56635
  Complete submission text file 0001193125-17-012320.txt   318376
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-212784 | Film No.: 17533473
SIC: 2834 Pharmaceutical Preparations